|
6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel Suppliers list
|
|
| | 6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel Basic information |
| Product Name: | 6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel | | Synonyms: | 6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel | | CAS: | 2531424-25-4 | | MF: | C14H19N7O9S | | MW: | 461.41 | | EINECS: | | | Product Categories: | | | Mol File: | 2531424-25-4.mol | ![6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel Structure](CAS/20211123/GIF/2531424-25-4.gif) |
| | 6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel Chemical Properties |
| | 6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel Usage And Synthesis |
| | 6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel Preparation Products And Raw materials |
|
|
Tag:6-Oxa-4,7,9-triazadec-7-enoic acid, 5-oxo-8- [(4R,7R,8S)-4,5,6,8-tetrahydro-1-methyl-6-oxo5-(sulfooxy)-1H-4,7-methanopyrazolo[3,4-e] [1,3]diazepin-8-yl]-, (7Z)-rel(2531424-25-4)
Related Product Information
|